LIPOPOLYSACCHARIDE-PRECONDITIONED MESENCHYMAL STEM CELL TRANSPLANTATION ATTENUATES CRITICAL PERSISTENT INFLAMMATION IMMUNE SUPPRESSION AND CATABOLISM SYNDROME IN MICE-Reference-Cited by-同舟云学术

LIPOPOLYSACCHARIDE-PRECONDITIONED MESENCHYMAL STEM CELL TRANSPLANTATION ATTENUATES CRITICAL PERSISTENT INFLAMMATION IMMUNE SUPPRESSION AND CATABOLISM SYNDROME IN MICE

Published:2022-09-27 Issue:5 Volume:58 Page:417-425
ISSN:1073-2322
Container-title:Shock
language:en
Short-container-title:Shock

Author:

Chen Xiancheng,Chen Ming,Yang Yang,Xu Can,Lu Huimin,Xu Yali,Li Xiaojing,Wei Yu,Zhu Zhanghua,Ding Yitao,Yu Wenkui

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine,Emergency Medicine

Reference35 articles.

1. Chronic critical illness and the persistent inflammation, immunosuppression, and catabolism syndrome;Front Immunol,2018

2. Current epidemiology of surgical sepsis: discordance between inpatient mortality and 1-year outcomes;Ann Surg,2019

3. The development of chronic critical illness determines physical function, quality of life, and long-term survival among early survivors of sepsis in surgical ICUs;Crit Care Med,2019

4. Abdominal sepsis patients have a high incidence of chronic critical illness with dismal long-term outcomes;Am J Surg,2020

5. Mouse model of critical persistent inflammation, immunosuppression, and catabolism syndrome;Shock,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PREDICTIVE VALUE OF SOLUBLE PROGRAMMED CELL DEATH LIGAND-1 IN THE PROGRESSION OF SEPTIC PATIENTS TO CHRONIC CRITICAL ILLNESS IN THE INTENSIVE CARE UNIT: A PROSPECTIVE OBSERVATIONAL CLINICAL STUDY;Shock;2023-06-03

2. Inhibition of DDX3X alleviates persistent inflammation, immune suppression and catabolism syndrome in a septic mice model;International Immunopharmacology;2023-04